NCT05464875 A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors Status RECRUITING Phase N/A
NCT05461664 Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA Status RECRUITING Phase N/A
NCT05440357 Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study Status RECRUITING Phase N/A
NCT05408897 Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD Status RECRUITING Phase N/A
NCT05400018 Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients Status COMPLETED Phase N/A
NCT05385549 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk Status RECRUITING Phase PHASE2
NCT05381753 Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World Status COMPLETED Phase N/A
NCT05245968 A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05197933 Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach Status UNKNOWN Phase NA
NCT05132738 Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy Status UNKNOWN Phase NA
NCT05080621 Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST) Status WITHDRAWN Phase PHASE1/PHASE2
NCT05001204 68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor Status UNKNOWN Phase EARLY_PHASE1
NCT04825574 Study for Patients Previously Treated in Avapritinib Clinical Trials Status COMPLETED Phase PHASE4
NCT04825470 Liver Transplantation for Unresectable GIST Liver Metastases Status NOT_YET_RECRUITING Phase NA
NCT04584008 Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics Status ACTIVE_NOT_RECRUITING Phase NA
NCT04409223 Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib Status TERMINATED Phase PHASE3